GreenLight Biosciences is a bioproduction company that has developed what it terms “a revolutionary cell-free manufacturing platform”.
The cell-free platform is capable of synthesizing complex chemicals through a sustainable, clean, biological process at costs that can be 5x-1,000x lower than traditional comparable fermentation or organic synthesis, the company says.
CEO Andrey Zarur gave this illuminating presentation on the company and technology at ABLC Next 2016.
